A Study to Evaluate S227928 as a Single Agent and in Combination With Venetoclax in Patients With R/R AML, MDS/AML, or CMML
Servier
Servier
Nerviano Medical Sciences
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
NextCure, Inc.
Novartis
Kahr Medical
Amgen
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC